Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXK7D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,262
Award facts
- Contract value 100% obligated
- $41,261.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,261.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pen injections on December 12, 2025, with completion scheduled for December 15, 2025. This non-competitive delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health System and other government healthcare programs.
The delivery order represents a specialized pharmaceutical procurement supporting military and defense healthcare operations. Zepbound is a GLP-1 receptor agonist indicated for weight management and is among the broader range of medications AmerisourceBergen supplies through its DLA contracts, which encompass diabetes treatments, neurological medications, pain management pharmaceuticals, vaccines, and medical devices. The IDC vehicle allows the company to fulfill diverse federal medical supply requirements with flexible ordering and firm fixed pricing, positioning AmerisourceBergen as a primary supplier within the Defense Logistics Agency's pharmaceutical supply chain serving military personnel, veterans, and related government healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FXK7D?
SPE2DR26FXK7D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FXK7D worth?
The government has obligated $41,262 on SPE2DR26FXK7D.
Is contract SPE2DR26FXK7D an order under another contract?
Yes. SPE2DR26FXK7D is a delivery order under SPE2DR25D6037, an indefinite delivery contract.
Was contract SPE2DR26FXK7D competed?
The extent of competition for SPE2DR26FXK7D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award